Physician profile
Johnathan L Chappell
NPI 1831385897
$2,728.38
in general payments reported to CMS, 2019-2025
17 companies · $1,691 in 2025
The $1,691 reported for 2025 was more than what a typical Dermatology provider received nationally (typical 2025 total: $772).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $136 · 2020: $143 · 2021: $127 · 2022: $84.42 · 2023: $162 · 2024: $385 · 2025: $1,691.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $1,500 · Food and Beverage: $738.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $1,500.00 |
| Food and Beverage | $737.59 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Journey Medical Corporation | $1,500.00 | 2025 | |
| Abbvie INC. | $328.17 | 2020-2025 | Skyrizi |
| Galderma Laboratories, L.P. | $226.03 | 2019-2025 | Nemluvio |
| E.R. Squibb & Sons, L.L.C. | $151.70 | 2024 | Sotyktu |
| Janssen Biotech, INC. | $122.54 | 2019-2023 | Tremfya |
| Dermavant Sciences, INC. | $101.43 | 2023-2024 | Vtama |
| Mayne Pharma Commercial LLC | $45.80 | 2019-2020 | |
| Lilly USA, LLC | $44.22 | 2024 | Olumiant, Taltz |
| Regeneron Healthcare Solutions, INC. | $35.93 | 2020-2022 | |
| Pfizer INC. | $34.41 | 2020-2021 | |
| Sun Pharmaceutical Industries INC. | $24.34 | 2024 | |
| Incyte Corporation | $23.72 | 2023 | Opzelura |
| Amgen INC. | $23.15 | 2023 | Otezla |
| Ucb, INC. | $20.86 | 2021 | |
| Organon LLC | $16.75 | 2025 |
Show all 17 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Paratek Pharmaceuticals, INC. | $14.85 | 2025 | Nuzyra |
| Ortho Dermatologics, A Division of Bausch Health US, LLC | $14.48 | 2021 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Johnathan Chappell listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.